Generic Name DEUCRAVACITINIB Review Date Began Mon, 09/19/2022 - 12:00 Review Date Completed Tue, 11/01/2022 - 12:00 Conclusion Clinical Edit Committee Month Thu, 12/01/2022 - 12:00 Sun, 01/01/2023 - 12:00